Researchers from the Royal College of Surgeons in Ireland (RCSI) and Beaumont Hospital have made a breakthrough in understanding the mechanisms behind the most severe form of hereditary emphysema and how protein treatments can improve the condition. The findings of this study may also lead to new treatments for patients with smoker’s emphysema.


Researchers from the Alpha One Foundation, the Royal College of Surgeons in Ireland and Harvard University have made a major breakthrough in identifying people who have an increased risk of developing COPD (chronic obstructive pulmonary disease) due to a combination of 1 copy of the Z Alpha-1 gene (MZ carriers) and exposure to cigarette smoke.


The annual scientific meeting of the Irish Thoracic Society for 2010 will take place this weekend (5th and 6th of November) in Cork. The Alpha One Foundation will have a stand at the event along with four posters. This meeting is a great chance to increase awareness of AATD and our targeted detection programme among consultants, respiratory scientists, nurses and physiotherapists.


As we head towards winter it's time again for Alpha-1 patients to contact their GPs to get the annual flu vaccine. Vaccines are the best line of defence we have against a flu virus as the flu vaccine reduces infection and associated illnesses and hospitalisation.

For more information please see the HSE website at: